Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASTERMIND - Variation in T2D Treatment Response
NCT01847144Phase 4Completed
- Sponsor
- Royal Devon University Healthcare NHS Foundation Trust
- Start
- Apr 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gliclazide, sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Royal Devon University Healthcare NHS Foundation Trust. Started Apr 2013; status: completed.
02
Drugs
gliclazidesitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01847144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01847144.